This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Transforming Growth Factor Beta-2 (TGFB2)
Product Overview
BioVenic's Recombinant Equine Transforming Growth Factor Beta-2 (TGFB2) is a recombinant protein expressed from Mammalian expression system. Its predicted molecular weight is 13 kDa. The purity is greater than 95% (SDS-PAGE). The endotoxin level is <0.01 EU/μg (LAL).
Specifications
Target Information
Transforming growth factor-beta 2 (TGF-β2) is a secreted protein known as a cytokine that performs many cellular functions and plays a vital role during embryonic development. Research has shown that treatment of equine bone marrow-derived mesenchymal stem cells with TGF-β2 significantly increases the production of paracrine factors and extracellular matrix molecules important for tendon healing and promotes tenocyte migration in vitro.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquote as needed and store at -20°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -20°C for 3 months.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Dissolve the lyophilized protein in distilled water. Avoid mixing by vortexing or pipetting. It is not recommended to reconstitute to a concentration < 100 μg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Koch, D. W. et al. TGF-β2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing. Stem cell research & therapy. 2022, 13: 477.